Cohort C1 & C2: KTX-1001 + Carfilzomib (KYPROLIS®) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Carfilzomib (KYPROLIS®), Dexamethasone

Filter by location:

San Francisco, California1 trial

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.